Sign In
Buy SIGA
$4.29
-0.0300 (-0.694%)
At Close: Jun 03, 2026
SIGA Technologies CEO to Speak at NCT USA Conference September 8, 2021
01:16pm, Tuesday, 07'th Sep 2021
NEW YORK, Sept. 07, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that Dr. Phil Gomez, the Company's Chief Executiv
SIGA Technologies, Inc. (SIGA) CEO Phil Gomez Q2 2021 Results - Earnings Call Transcript
07:43pm, Sunday, 08'th Aug 2021
SIGA Technologies, Inc. (SIGA) CEO Phil Gomez Q2 2021 Results - Earnings Call Transcript
SIGA Technologies to Host Business Update Call on August 5th, 2021 Following Release of Second Quarter 2021 Financial Results
04:15pm, Thursday, 29'th Jul 2021
NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference
NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has
SIGA Supplies TPOXX® (Tecovirimat) as Compassionate Treatment for Monkeypox Case in the United Kingdom
07:30am, Wednesday, 30'th Jun 2021
NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it prov
4 Undervalued Biotech Stocks That Belong On Every Investor's Buy List
04:36pm, Thursday, 17'th Jun 2021
Searching for undervalued biotech stocks? Here are 4 biotech stocks to buy for a mix of value and growth in any portfolio.
7 Small-Cap Biotech Stocks to Watch for Upcoming Catalysts
03:45pm, Wednesday, 12'th May 2021
Small-cap stocks in the biotech space have been in a slump, but these seven companies could see big moves just around the corner. The post 7 Small-Cap Biotech Stocks to Watch for Upcoming Catalysts ap
SIGA Technologies, Inc. (SIGA) CEO Phil Gomez on Q1 2021 Results - Earnings Call Transcript
01:57am, Sunday, 09'th May 2021
SIGA Technologies, Inc. (SIGA) CEO Phil Gomez on Q1 2021 Results - Earnings Call Transcript
SIGA Announces New Drug Application Filing with FDA for Intravenous Formulation of TPOXX
07:30am, Tuesday, 04'th May 2021
- Important for Patients Who Cannot Swallow Oral Capsules - - Important for Patients Who Cannot Swallow Oral Capsules -
SIGA Technologies: Biodefense Pharma Unlocks New Value Abroad For TPOXX
10:06pm, Tuesday, 27'th Apr 2021
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company developing drugs for health security and infectious diseases globally with a market niche in smallpox servicing various government
MUMBAI, India, March 23, 2021 /PRNewswire/ -- Cipla Therapeutics, an affiliate of Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (herein referred to as "Cipla") and SIGA Technologies, Inc. (SIGA) (NASDA
SIGA Technologies, Inc. (SIGA) CEO Phil Gomez on Q4 2020 Results - Earnings Call Transcript
06:39pm, Thursday, 04'th Mar 2021
SIGA Technologies, Inc. (SIGA) CEO Phil Gomez on Q4 2020 Results - Earnings Call Transcript
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2020
04:05pm, Thursday, 04'th Mar 2021
- Approximately 363,000 Courses of Oral TPOXX® Delivered to U.S. Government in 2020 –
SIGA Technologies to Host Business Update Call on March 4, 2021 Following Release of Year End 2020 Financial Results
07:30am, Friday, 26'th Feb 2021
NEW YORK, Feb. 26, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that managem
3 Magic Formula Stocks for the Value Investor
03:26pm, Sunday, 21'st Feb 2021
If you want to increase your chances of beating the market, one method is to select stocks that rank highly according to the "Magic Formula" criteria.
